[Effect of Deseril-Retard and Migristen on the excretion of 5-hydroxy-indoloacetic acid and P-hydroxy-M-methoxymandelic acid in the urine of patients suffering from migraine].
D000293:Adolescent; D000328:Adult; D000588:Amines / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine*; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy* / Q000652:urine; D010640:Phenothiazines / Q000627:therapeutic use*; D013997:Time Factors; D014642:Vanilmandelic Acid / Q000652:urine
D000588:Amines; D010640:Phenothiazines; D006897:Hydroxyindoleacetic Acid; D014642:Vanilmandelic Acid
Wpływ podawania deserilu-retard i migristénu na wydalanie kwasu 5-hydroksyindolooctowego (5-HIO) i kwasu 3-metoksy-4-hydroksy-migdałowego (HMM) w moczu u cierpiacych na migrene.